Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.
State Department objects to Tanzania LGBT persecution without noting health impacts; IAS delineates damage to HIV responses
The U.S. Department of State today issued an expression of concern over Tanzanian government actions targeting its LGBT population, noting that the violence, oppression and intimidation […]
49th Union World Conference on Lung Health: 90 percent of participants in short-course XDR-TB regimen cured after six months
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
As cases of polio-like illness triple from previous year, public health officials increase surveillance, follow-up
Two years after launching surveillance of acute flaccid myelitis, and amid climbing cases, CDC continues to seek cause, and notes gaps in knowledge of long term […]